Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial

DA Corley, P Katz, JM Wo, A Stefan, M Patti… - Gastroenterology, 2003 - Elsevier
Background & Aims : Gastroesophageal reflux disease is a prevalent disorder that often
requires long-term medical therapy or surgery. The United States Food and Drug Administration …

Non-CPAP therapies in obstructive sleep apnoea

WJ Randerath, J Verbraecken, S Andreas, G Bettega… - 2011 - Eur Respiratory Soc
In view of the high prevalence and the relevant impairment of patients with obstructive sleep
apnoea syndrome (OSAS) lots of methods are offered which promise definitive cures for or …

Neurohumoral activation as a link to systemic manifestations of chronic lung disease

S Andreas, SD Anker, PD Scanlon, VK Somers - Chest, 2005 - Elsevier
COPD is a major cause of death and disability worldwide. Treatment of COPD improves lung
function but is unlikely to slow the steady downhill course of the disease or reduce mortality…

Marked sympathetic activation in patients with chronic respiratory failure

…, CP Criee, G Hasenfuss, S Andreas - American Journal of …, 2001 - atsjournals.org
The autonomic nervous system may be disturbed in chronic respiratory failure. We tested
the hypothesis that there is increased sympathetic activity in patients with chronic hypoxemia. …

Secondhand smoke as an acute threat for the cardiovascular system: a change in paradigm

…, K Schäfer, S Konstantinides, S Andreas - European Heart …, 2006 - academic.oup.com
The evidence that active smoking is a risk factor for cardiovascular disease (CVD) and the
leading cause of preventable death is overwhelming. However, numerous epidemiological …

Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep

W Randerath, J Verbraecken, S Andreas… - European respiratory …, 2017 - Eur Respiratory Soc
The complexity of central breathing disturbances during sleep has become increasingly
obvious. They present as central sleep apnoeas (CSAs) and hypopnoeas, periodic breathing …

Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry

…, J Klotsche, D Koschel, S Andreas… - European …, 2015 - Eur Respiratory Soc
After introduction of the new international guidelines on idiopathic pulmonary fibrosis (IPF)
in 2011, we investigated clinical management practices for patients with IPF according to …

Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit

CA Jiménez-Ruiz, S Andreas, KE Lewis… - European respiratory …, 2015 - Eur Respiratory Soc
Chronic obstructive pulmonary disease (COPD), lung cancer, asthma and pulmonary
tuberculosis are common pulmonary diseases that are caused or worsened by tobacco smoking. …

Disconnected pancreatic tail syndrome: potential for endoscopic therapy and results of long-term follow-up

C Lawrence, DA Howell, AM Stefan, DE Conklin… - Gastrointestinal …, 2008 - Elsevier
BACKGROUND: Limited published data exist that address the incidence and outcomes of
patients with complete pancreatic-duct disruption. OBJECTIVE: Report on a single-center …

Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the …

…, M Held, J Klotsche, S Andreas… - European …, 2020 - Eur Respiratory Soc
Objective There is a paucity of observational data on antifibrotic therapy for idiopathic pulmonary
fibrosis (IPF). We aimed to assess the course of disease of IPF patients with and without …